1887
Rapid communication Open Access
Like 0

Abstract

We report the emergence and evolution of a circulating vaccine-derived poliovirus type 1 (cVDPV1) outbreak in Israel, linked to a vaccine-associated paralytic poliomyelitis case. Whole genome sequencing revealed a strong genetic link between the Sabin-like poliovirus type 1 variant from the case and pre-VDPV1 and VDPV1 isolated from environmental samples collected in October 2024–April 2025, mostly in Jerusalem. Early detection was made possible by Israel’s robust environmental surveillance and advanced sequencing technologies, enabling a rapid public health response.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2025.30.34.2500605
2025-08-28
2025-09-03
/content/10.2807/1560-7917.ES.2025.30.34.2500605
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/30/34/eurosurv-30-34-1.html?itemId=/content/10.2807/1560-7917.ES.2025.30.34.2500605&mimeType=html&fmt=ahah

References

  1. Burki T. Vaccine-derived poliovirus cases exceed wild types. Lancet Infect Dis. 2019;19(2):140.  https://doi.org/10.1016/S1473-3099(19)30012-X  PMID: 31876508 
  2. World Health Organization (WHO). Detection of circulating vaccine derived polio virus 2 (cVDPV2) in environmental samples– the United Kingdom of Great Britain and Northern Ireland and the United States of America. Geneva: WHO; 2022. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON408
  3. Böttcher S, Kreibich J, Wilton T, Saliba V, Blomqvist S, Al-Hello H, et al. Detection of circulating vaccine-derived poliovirus type 2 (cVDPV2) in wastewater samples: a wake-up call, Finland, Germany, Poland, Spain, the United Kingdom, 2024. Euro Surveill. 2025;30(3):2500037.  https://doi.org/10.2807/1560-7917.ES.2025.30.3.2500037  PMID: 39850005 
  4. Zuckerman NS, Bucris E, Morad-Eliyahu H, Weiss L, Vasserman R, Fratty IS, et al. Environmental surveillance of a circulating vaccine-derived poliovirus type 2 outbreak in Israel between 2022 and 2023: a genomic epidemiology study. Lancet Microbe. 2024;5(10):100893.  https://doi.org/10.1016/S2666-5247(24)00116-2  PMID: 39284332 
  5. Weil M, Sofer D, Shulman LM, Weiss L, Levi N, Aguvaev I, et al. Environmental surveillance detected type 3 vaccine-derived polioviruses in increasing frequency at multiple sites prior to detection of a poliomyelitis case. Sci Total Environ. 2023;871:161985.  https://doi.org/10.1016/j.scitotenv.2023.161985  PMID: 36739034 
  6. World Health Organization (WHO). Polio Laboratory Manual. Geneva: WHO; 2004. Available from: https://iris.who.int/bitstream/handle/10665/68762/WHO_IVB_04.10.pdf
  7. World Health Organization (WHO). S1. Supplement to the WHO Polio Laboratory Manual. An alternative test algorithm for poliovirus isolation and characterization. Geneva: WHO; 2020. Available from: https://polioeradication.org/wp-content/uploads/2017/05/NewAlgorithmForPoliovirusIsolationSupplement1.pdf
  8. World Health Organization (WHO). Classification and reporting of vaccine-derived polioviruses (VDPV). Geneva: WHO; 2016. Available from: https://polioeradication.org/wp-content/uploads/2016/09/Reporting-and-Classification-of-VDPVs_Aug2016_EN.pdf
  9. Platt LR, Estívariz CF, Sutter RW. Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden. J Infect Dis. 2014;210(Suppl 1) Suppl 1;S380-9.  https://doi.org/10.1093/infdis/jiu184  PMID: 25316859 
  10. Laassri M, Dragunsky E, Enterline J, Eremeeva T, Ivanova O, Lottenbach K, et al. Genomic analysis of vaccine-derived poliovirus strains in stool specimens by combination of full-length PCR and oligonucleotide microarray hybridization. J Clin Microbiol. 2005;43(6):2886-94.  https://doi.org/10.1128/JCM.43.6.2886-2894.2005  PMID: 15956413 
  11. Hadfield J, Megill C, Bell SM, Huddleston J, Potter B, Callender C, et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 2018;34(23):4121-3.  https://doi.org/10.1093/bioinformatics/bty407  PMID: 29790939 
  12. Jain M, Olsen HE, Paten B, Akeson M. The Oxford Nanopore MinION: delivery of nanopore sequencing to the genomics community. Genome Biol. 2016;17(1):239.  https://doi.org/10.1186/s13059-016-1103-0  PMID: 27887629 
  13. Namageyo-Funa A, Greene SA, Henderson E, Traoré MA, Shaukat S, Bigouette JP, et al. Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2023-June 2024. MMWR Morb Mortal Wkly Rep. 2024;73(41):909-16.  https://doi.org/10.15585/mmwr.mm7341a1  PMID: 39418214 
  14. Zuckerman NS, Bar-Or I, Sofer D, Bucris E, Morad H, Shulman LM, et al. Emergence of genetically linked vaccine-originated poliovirus type 2 in the absence of oral polio vaccine, Jerusalem, April to July 2022. Euro Surveill. 2022;27(37):2200694.  https://doi.org/10.2807/1560-7917.ES.2022.27.37.2200694  PMID: 36111556 
  15. Burns CC, Diop OM, Sutter RW, Kew OM. Vaccine-derived polioviruses. J Infect Dis. 2014;210(Suppl 1):S283-93.  https://doi.org/10.1093/infdis/jiu295  PMID: 25316847 
/content/10.2807/1560-7917.ES.2025.30.34.2500605
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error